RAGE Gene Deletion Inhibits the Development and Progression of Ductal Neoplasia and Prolongs Survival in a Murine Model of Pancreatic Cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RAGE Gene Deletion Inhibits the Development and Progression of Ductal Neoplasia and Prolongs Survival in a Murine Model of Pancreatic Cancer
Authors
Keywords
-
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 16, Issue 1, Pages 104-112
Publisher
Springer Nature
Online
2011-11-03
DOI
10.1007/s11605-011-1754-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Precursor Lesions of Pancreatic Adenocarcinoma in PET-CT in a Genetically Engineered Mouse Model of Pancreatic Cancer
- (2015) Volker Fendrich et al. NEOPLASIA
- Abstract 2114: Deletions/Duplications detection by MLPA in Chilean families with hereditary colorectal cancer: Lynch syndrome and FAP
- (2011) Claudia Hurtado et al. CANCER RESEARCH
- Inactivation of Brca2 Promotes Trp53-Associated but Inhibits KrasG12D-Dependent Pancreatic Cancer Development in Mice
- (2011) Matthew Rowley et al. GASTROENTEROLOGY
- RAGE: The beneficial and deleterious effects by diverse mechanisms of actions
- (2011) Sun-Ho Han et al. MOLECULES AND CELLS
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- The redox protein HMGB1 regulates cell death and survival in cancer treatment
- (2010) Daolin Tang et al. Autophagy
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal Cells
- (2010) Kyoung Eun Lee et al. CANCER CELL
- The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model
- (2010) A. Mohammed et al. Cancer Prevention Research
- Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer
- (2010) Tomáš Krechler et al. CLINICAL BIOCHEMISTRY
- RAGE Signaling Significantly Impacts Tumorigenesis and Hepatic Tumor Growth in Murine Models of Colorectal Carcinoma
- (2010) Joseph DiNorcia et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Fueling inflammation at tumor microenvironment: the role of multiligand/rage axis
- (2009) A. Rojas et al. CARCINOGENESIS
- The receptor RAGE: Bridging inflammation and cancer
- (2009) Astrid Riehl et al. Cell Communication and Signaling
- The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
- (2009) R Kang et al. CELL DEATH AND DIFFERENTIATION
- RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
- (2009) Ravichandran Ramasamy et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The expression of HMGB1 protein and its receptor RAGE in human malignant tumors
- (2009) Nora Kostova et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- Localized Release of Serotonin (5-Hydroxytryptamine) by a Fecal Pellet Regulates Migrating Motor Complexes in Murine Colon
- (2008) Dante J. Heredia et al. GASTROENTEROLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now